{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,30]],"date-time":"2025-08-30T17:01:31Z","timestamp":1756573291199},"reference-count":14,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Ligue R\u00e9gional de la Lutte Contre le Cancer (Comite de Seine Mari-time, France)"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1016\/j.leukres.2017.06.006","type":"journal-article","created":{"date-parts":[[2017,6,17]],"date-time":"2017-06-17T06:46:31Z","timestamp":1497681991000},"page":"53-57","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Heterogeneous epigenetic regulation of HACE1 in Burkitt- Lymphoma-derived cells"],"prefix":"10.1016","volume":"60","author":[{"given":"Abdelilah","family":"Bouzelfen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hafid","family":"Kora","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marion","family":"Alcantara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philippe","family":"Bertrand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Baptiste","family":"Latouche","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabrice","family":"Jardin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.leukres.2017.06.006_bib0005","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1038\/ng.154","article-title":"Combinatorial patterns of histone acetylations and methylations in the human genome","volume":"40","author":"Wang","year":"2008","journal-title":"Nat. Genet."},{"key":"10.1016\/j.leukres.2017.06.006_bib0010","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.leukres.2016.04.007","article-title":"HACE1 is a putative tumor suppressor gene in B-cell lymphomagenesis and is down-regulated by both deletion and epigenetic alterations","volume":"45","author":"Bouzelfen","year":"2016","journal-title":"Leuk. Res."},{"key":"10.1016\/j.leukres.2017.06.006_bib0015","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1101\/gad.1524107","article-title":"Pharmacologic disruption of Polycomb-repressive complex 2-mediated gene repression selectively induces apoptosis in cancer cells","volume":"21","author":"Tan","year":"2007","journal-title":"Gene Dev."},{"key":"10.1016\/j.leukres.2017.06.006_bib0020","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1158\/1535-7163.MCT-09-0013","article-title":"DZNep is a global histone methylation inhibitor that reactivates developmental genes not silenced by DNA methylation","volume":"8","author":"Miranda","year":"2009","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.leukres.2017.06.006_bib0025","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1182\/blood-2009-03-213496","article-title":"Combined epigenetic therapy with the histone methyltransferase EZH2 inhibitor 3-deazaneplanocin A and the histone deacetylase inhibitor panobinostat against human AML cells","volume":"114","author":"FiskusW. Wang","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2017.06.006_bib0030","doi-asserted-by":"crossref","first-page":"2830","DOI":"10.1182\/blood-2010-07-294827","article-title":"The histone methyltransferase inhibitor, DZNep, up-regulates TXNIP, increases ROS production, and targets leukemia cells in AML","volume":"118","author":"Zhou","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2017.06.006_bib0035","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.bbrc.2013.07.128","article-title":"DZNep, inhibitor of S-adenosylhomocysteine hydrolase, down-regulates expression of SETDBI H3K9me3 HMTase in human lung cancer cells","volume":"438","author":"Lee","year":"2013","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.leukres.2017.06.006_bib0040","doi-asserted-by":"crossref","first-page":"e98176","DOI":"10.1371\/journal.pone.0098176","article-title":"3-Deazaneplanocin A (DZNep), an inhibitor of the histone methyltransferase EZH2, induces apoptosis and reduces cell migration in chondrosarcoma cells","volume":"9","author":"Girard","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.leukres.2017.06.006_bib0045","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1093\/jnci\/92.18.1460","article-title":"Aberrant methylation of gene promoters in cancer \u2013concepts, misconcepts, and promise","volume":"92","author":"Baylin","year":"2000","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.leukres.2017.06.006_bib0050","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.cell.2007.01.029","article-title":"The epigenomics of cancer","volume":"128","author":"Jones","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.leukres.2017.06.006_bib0055","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1056\/NEJMra023075","article-title":"Gene silencing in cancer in association with promoter hypermethylation","volume":"349","author":"Herman","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.leukres.2017.06.006_bib0060","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/S0168-9525(99)01971-X","article-title":"DNA hypermethylation in tumorigenesis: epigenetics joins genetics","volume":"16","author":"Baylin","year":"2000","journal-title":"Trends Genet."},{"key":"10.1016\/j.leukres.2017.06.006_bib0065","doi-asserted-by":"crossref","first-page":"4056","DOI":"10.1128\/MCB.23.12.4056-4065.2003","article-title":"Methylation of adjacent CpG sites affects Sp1\/Sp3 binding and activity in the p21 (Cip1) promoter","volume":"23","author":"Zhu","year":"2003","journal-title":"Mol. Cell. Biol."},{"issue":"8","key":"10.1016\/j.leukres.2017.06.006_bib0070","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1038\/nrc.2016.62","article-title":"The role of enhancers in cancer","volume":"16","author":"Sur","year":"2016","journal-title":"Nat. Rev. Cancer"}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212617304599?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212617304599?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T12:07:58Z","timestamp":1620994078000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212617304599"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":14,"alternative-id":["S0145212617304599"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2017.06.006","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Heterogeneous epigenetic regulation of HACE1 in Burkitt- Lymphoma-derived cells","name":"articletitle","label":"Article Title"},{"value":"Leukemia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.leukres.2017.06.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}